Cargando…
Metastatic Dermatosis in Breast Carcinoma on Adjuvant Trastuzumab: Is Skin a Sanctuary Site in Human Epidermal Growth Factor Receptor-2-Amplified Disease?
Cutaneous metastasis (CM) from internal malignancies is commonly seen. Sometimes, skin metastases can be the first sign of advanced cancer or an indicator of cancer recurrence. Cases of breast cancer with cutaneous progression after or during trastuzumab therapy have been described in the past, freq...
Autores principales: | Sehrawat, Amit, Kotwal, Sumedha A., Parthasarathy, K. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124245/ https://www.ncbi.nlm.nih.gov/pubmed/30210167 http://dx.doi.org/10.4103/ijd.IJD_234_18 |
Ejemplares similares
-
Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary
por: Giarratano, Tommaso, et al.
Publicado: (2018) -
Sanctuary /
por: Faulkner, William, 1897-1962
Publicado: (1980) -
Sanctuary
por: Kellerman, Faye
Publicado: (1994) -
Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2020) -
Role of chemotherapy prior to orchiectomy in metastatic testicular cancer—is testis really a sanctuary site?
por: Reddy, B Vinusha, et al.
Publicado: (2014)